retatrutide clinical trial weight loss results in 28 percent average Retatrutide shows 30% weight loss

Mol Med (2019) 26:6

Important safety considerations include: Separate fiber supplements from medications : Take fiber supplements at least 2 hours apart from oral medications to avoid potential interference with absorption Monitor for obstruction symptoms : Severe abdominal pain, inability to pass gas, or vomiting requires immediate medical evaluation, as FDA labels for GLP-1 medications include rare postmarketing reports of intestinal obstruction (ileus) [1] [2] Coordinate with healthcare providers : Patients with inflammatory bowel disease, diverticulitis history, or other gastrointestinal conditions need individualized fiber recommendations Adjust fluid intake appropriately : Follow medical guidance if you have conditions requiring fluid restriction Patients should contact their healthcare provider if gastrointestinal symptoms persist despite dietary modifications, worsen significantly, or include warning signs such as blood in stool, unintentional weight loss beyond expected therapeutic effects, or severe abdominal pain

[DOI] [PMC free article] [PubMed] [Google Scholar] 156.Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al

Telehealth platforms like TrimRx offer a free assessment quiz that determines eligibility for a personalized treatment plan

We are still at the cusp of trying to understand the role of these gut organisms in health, disease and surgical success and, more importantly, whether this information can be leveraged for the treatment of metabolic disease